Navigation Links
New Light on Jane Austen's Final Chapter
Date:12/2/2009

Novelist's symptoms point to death from TB, not Addison's, researcher says

WEDNESDAY, Dec. 2 (HealthDay News) -- The woman behind Pride and Prejudice and Emma may have died of tuberculosis rather than Addison's disease, as has long been believed, says one British scholar.

Since Jane Austen's death in 1817 at the age of 41, many historians and other experts have believed the cause was Addison's disease, which affects the adrenal glands and creates problems with blood pressure and heart function. The disease was always fatal until effective treatment became available in the 1950s.

But Katherine White, a member of the Addison's Disease Self-Help Group, analyzed Austen's letters in the two years before she died and concluded that the symptoms described by the writer suggest Addison's wasn't the culprit.

Austen said she experienced exhaustion, rheumatic pains, unusual skin discoloration and bilious attacks -- all of which could be symptoms of Addison's disease. However, she makes no mention of other symptoms -- generalized pain, weight loss, mental confusion and loss of appetite -- experienced by most people with the disease.

White noted that disseminated tuberculosis, affecting the joints and liver, "would have been more common in Jane Austen's time and would offer a simpler explanation for her symptoms."

Some medical historians have suggested that Austen could have acquired disseminated tuberculosis infection from cows or by drinking unpasteurized milk.

In 1964, physician and surgeon Zachary Cope suggested that Austen may have died from tubercular Addison's disease.

"...It is likely that Cope's hypothesis of infective tuberculosis as the source of her illness was at least partially correct, after all," White wrote.

The article was published online Nov. 30 in the journal Medical Humanities.

More information

The American Lung Association has more about tuberculosis .



-- Robert Preidt



SOURCE: BMJ specialist journals, news release, Nov. 30, 2009


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Stanford study highlights cost-effective method of lowering heart disease risks
2. Study shines more light on benefit of vitamin D in fighting cancer
3. Bacteria See the Light
4. Quantum light beams good for fast technology
5. Free will takes flight: how our brains respond to an approaching menace
6. New MRI finding sheds light on multiple sclerosis disease progressio
7. RA Drugs Linked to Slight Skin Cancer Risk
8. QUANTEL Intends to Strengthen its Dermatology/ Aesthetics Division With the Acquisition of WaveLight Aesthetic GmbH
9. REACH Registry Highlights That Patients With Peripheral Arterial Disease (PAD) Suffer High Rates of Heart Attack, Stroke, Hospitalization, and Death
10. Cardiovascular Technologies to be Highlighted at 5th Annual Cleveland Clinic Medical Innovation Summit, Oct. 1-3
11. First Circuit Court of Appeals Rules Against Philip Morris in Lights Class Action
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... Ellevate Network, the leading network for professional women, ... towards gender equality at their inaugural Summit in New York City in June. The ... social audience of over 3 million. To watch the Mobilize Women video, click ...
(Date:10/13/2017)... ... 2017 , ... “The Journey: From the Mountains to the Mission Field”: the ... in the Philippines. “The Journey: From the Mountains to the Mission Field” is the ... She has taught all ages and currently teaches a class of ladies at her ...
(Date:10/12/2017)... ... 2017 , ... The company has developed a suite of ... authorities worldwide. From Children’s to Adults 50+, every formula has been developed by ... , These products are also: Gluten Free, Non-GMO, Vegan, Soy Free, Non-Dairy*, Preservative ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... Hair Restoration, has recently contributed a medical article to the newly revamped ... Dr. Mohebi’s article spotlights the hair transplant procedure known as Follicular Unit ...
(Date:10/12/2017)... ... October 12, 2017 , ... Health ... interactive health literacy software tool, and the Cancer Patient Education Network (CPEN), an ... education, today announce a new strategic alliance. , As CPEN’s strategic partner, ...
Breaking Medicine News(10 mins):
(Date:9/25/2017)... , Sept. 25, 2017   Montrium ... Master File solutions, today—from the IQPC Trial Master ... , NL)—announced that EastHORN Clinical Services has ... clinical programs and TMF management. EastHORN, a leading ... eTMF platform to increase transparency to enable greater ...
(Date:9/23/2017)... , Sept. 22, 2017 Janssen Biotech, ... complete response letter from the U.S. Food and Drug ... approval of sirukumab for the treatment of moderately to ... indicates additional clinical data are needed to further evaluate ... to severely active RA. ...
(Date:9/22/2017)... 2017 AVACEN Medical (AVACEN) announced that its ... helping those with the widespread pain associated with fibromyalgia ... in Essex, England commented, "I ... experiencing no sleep at all, tremendous pain, with every ... recommend [the AVACEN 100] enough, how this has and ...
Breaking Medicine Technology: